Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $572.99 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Therapeutics Corporation | $228.52 | 3 | $0 (2023) |
| Abbott Laboratories | $123.50 | 1 | $0 (2022) |
| ABIOMED | $118.14 | 4 | $0 (2024) |
| Genmab U.S., Inc. | $82.92 | 1 | $0 (2024) |
| ABBVIE INC. | $19.91 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $201.06 | 5 | ABIOMED ($118.14) |
| 2023 | $248.43 | 4 | United Therapeutics Corporation ($228.52) |
| 2022 | $123.50 | 1 | Abbott Laboratories ($123.50) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $82.92 | General |
| Category: Oncology | ||||||
| 08/27/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $37.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $25.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $28.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/27/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2023 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $105.25 | General |
| 08/07/2023 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $102.87 | General |
| 02/09/2023 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/24/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: PAH | ||||||
| 05/05/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $123.50 | General |
| Category: Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 172 | 357 | $94,725 | $20,308 |
| 2022 | 4 | 202 | 518 | $154,504 | $29,842 |
| 2021 | 6 | 300 | 687 | $209,125 | $41,969 |
| 2020 | 6 | 328 | 713 | $215,547 | $43,958 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 89 | 242 | $55,902 | $12,112 | 21.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 62 | $20,522 | $4,669 | 22.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $7,692 | $1,317 | 17.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $6,090 | $1,149 | 18.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 11 | $2,519 | $561.00 | 22.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 16 | $2,000 | $498.88 | 24.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 73 | 258 | $85,398 | $16,687 | 19.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 83 | 213 | $49,203 | $9,653 | 19.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 23 | $14,743 | $2,822 | 19.1% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2022 | 24 | 24 | $5,160 | $680.23 | 13.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 101 | 371 | $122,801 | $24,794 | 20.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 116 | 231 | $53,361 | $10,737 | 20.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $9,615 | $1,942 | 20.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 21 | 22 | $9,570 | $1,930 | 20.2% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2021 | 19 | 19 | $7,543 | $1,738 | 23.0% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2021 | 28 | 29 | $6,235 | $828.78 | 13.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 98 | 392 | $129,752 | $26,653 | 20.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 154 | 244 | $56,364 | $11,489 | 20.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 16 | 16 | $10,256 | $2,108 | 20.6% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 19 | 20 | $7,940 | $1,872 | 23.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 11 | 11 | $4,785 | $978.54 | 20.5% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2020 | 30 | 30 | $6,450 | $857.46 | 13.3% |
About Emily Maiers, ARNP
Emily Maiers, ARNP is a Acute Care healthcare provider based in Davenport, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/06/2012. The National Provider Identifier (NPI) number assigned to this provider is 1649527045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Emily Maiers, ARNP has received a total of $572.99 in payments from pharmaceutical and medical device companies, with $201.06 received in 2024. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($572.99).
As a Medicare-enrolled provider, Maiers has provided services to 1,002 Medicare beneficiaries, totaling 2,275 services with total Medicare billing of $136,076. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Davenport, IA
- Active Since 08/06/2012
- Last Updated 04/21/2021
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1649527045
Products in Payments
- CARDIOMEMS (Device) $123.50
- Impella (Device) $118.14
- Epkinly (Drug) $82.92
- TYVASO (Drug) $20.40
- TEFLARO (Drug) $19.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Davenport
Ms. Jessica Witter, Arnp, ARNP
Acute Care — Payments: $4,981
Shawna Duske, Acnp, ACNP
Acute Care — Payments: $2,062
Mrs. Heather Hitesman, Arnp, ARNP
Acute Care — Payments: $1,572
Lori Schwarm, Arnp, ARNP
Acute Care — Payments: $905.15
Gina Zelle, Dnp, Agacnp-Bc, DNP, AGACNP-BC
Acute Care — Payments: $901.58
Dr. Cheryl Ehrler, Dnp, Arnp, Agacnp-Bc, DNP, ARNP, AGACNP-BC
Acute Care — Payments: $855.05